Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Diers

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nursing in Critical Care|May 25, 2019
PROtocol-based MObilizaTION on intensive care units: stepped-wedge, cluster-randomized pilot study (Pro-Motion)Peter Nydahl, Ulf Günther, Anja Diers, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 25, 2021
[Disorientation and delirium assessment : A secondary analysis of a prospective, observational study]Ulf Guenther, Mirko Wolke, Hans-Christian Hansen, et al.
Critical Care Explorations|November 22, 2021
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock-A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, Andreas Weyland, Gernot Marx, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nursing in Critical Care|May 25, 2019
PROtocol-based MObilizaTION on intensive care units: stepped-wedge, cluster-randomized pilot study (Pro-Motion)Peter Nydahl, Ulf Günther, Anja Diers, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 25, 2021
[Disorientation and delirium assessment : A secondary analysis of a prospective, observational study]Ulf Guenther, Mirko Wolke, Hans-Christian Hansen, et al.
Critical Care Explorations|November 22, 2021
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock-A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, Andreas Weyland, Gernot Marx, et al.
Pageof 1